T. Rowe Price Associates »

Contineum Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $148k 11k 13.10
2025-12-31 $130k 11k 11.50

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
Henderson Group
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management

View all funds holding Contineum Therapeutics